🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Fluticasone Propionate 100 mcg

Found 128 matching trials

A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects

PHASE3

The primary aim of this study is to clarify the position of FF and FF/Vilan...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-03-27

Trial ID

NCT02094937

Treatments Being Tested

Fluticasone Furoate/Vilanterol Fluticasone Furoate 100 mcg Fluticasone Propionate 250 mcg Fluticasone Propionate 100 mcg Fluticasone Furoate Placebo Fluticasone Propionate Placebo

Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic Rhinitis

PHASE2

The aim of the study is to investigate the trial models, Vienna Challenge C...

Status

Completed

Location

GSK Investigational Site

Start Date

2006-03

Trial ID

NCT00400998

Treatments Being Tested

Fluticasone Propionate Matched FPANS placebo

Corrected QT (QTc) Study With Flucticasone Furoate and GW642444

PHASE1

A randomised, placebo controlled thorough QTc study to evaluate the effect ...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-06-23

Trial ID

NCT01209026

Treatments Being Tested

Fluticasone furoate (200 mcg)/GW642444 (25mcg) combination Fluticasone furoate (400 mcg)/GW642444 (50mcg) combination Placebo Inhaler Moxifloxacin 400mg Moxifloxacin placebo

ROTAHALER Device Optimization Study

PHASE1

This study will compare the pharmacokinetic (PK) of Fluticasone Propionate/...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-08-05

Trial ID

NCT01890863

Treatments Being Tested

Fluticasone Propionate / Salmeterol Xinafoate DISKUS Fluticasone Propionate / Salmeterol Xinafoate ROTACAP

Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover Study

PHASE4

The goal of this clinical trial is to determine if triple inhaled therapy w...

Status

Completed

Location

Narongkorn Saiphoklang

Start Date

2025-04-01

Trial ID

NCT06905483

Treatments Being Tested

Budesonide/Glycopyrronium/Formoterol (BGF)Fluticasone Furoate/Umeclidinium/Vilanterol (FUV)

Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

N/A

The purpose of this study is to evaluate the site and mechanisms responsibl...

Status

Recruiting

Location

Arthur F Gelb Medical Corporation

Start Date

2007-10-25

Trial ID

NCT00576069

Treatments Being Tested

budesonide/formoterol fluticasone/salmeterol mometasone/formoterol Prednisone

Changes in the Lung Clearance Index in Pediatric Patients With Asthma

The multiple breath washout (MBW) is one of pulmonary function test that di...

Status

Unknown

Location

Hospital Infantil de Mexico Federico Gomez

Start Date

2016-03

Trial ID

NCT02678949

Treatments Being Tested

Inhaled Fluticasone 50 mcg/twice day Inhaled Fluticasone 100 mcg/twice day Inhaled Albuterol

Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD).

PHASE4

This is a multi-center, randomized, double-blind, parallel-group study. The...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-01-28

Trial ID

NCT01957150

Treatments Being Tested

Fluticasone Furoate/Vilanterol Vilanterol

Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics

The purpose of this study is to determine whether patients with asthma who ...

Status

Completed

Location

Maternal and Child Health Sciences, Ninewells Hospital and Medical School

Start Date

2007-08

Trial ID

NCT00655616

Treatments Being Tested

Montelukast Placebo Salmeterol, Montelukast

Fall Epidemic Viral Pediatric Study

PHASE4

Study ADA113872 is an exploratory 16-week multi-centre, randomized, double-...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-08

Trial ID

NCT01192178

Treatments Being Tested

FLOVENT™ DISKUS™ 100 mcg BID ADVAIR™ DISKUS™ 100/50 mcg BID

Previous Next